This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

This commentary was originally published by The Conversation. Medical marijuana could soon be reclassified into a medical ...

Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...

Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the ...